Androgen supplementation in eugonadal men with osteoporosis—effects of 6 months of treatment on bone mineral density and cardiovascular risk factors
- 29 February 1996
- Vol. 18 (2), 171-177
- https://doi.org/10.1016/8756-3282(95)00441-6
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Effect of long‐term oral testosterone undecanoate treatment on prostate volume and serum prostate‐specific antigen concentration in eugonadal middle‐aged menThe Prostate, 1993
- Pathogenesis of Vertebral Crush Fractures in MenAge and Ageing, 1992
- Effects of testosterone and venesection on spinal and peripheral bone mineral in six hypogonadal men with hemochromatosisJournal of Bone and Mineral Research, 1991
- Contraceptive efficacy of testosterone-induced azoospermia in normal menThe Lancet, 1990
- Effect of Fluoride Treatment on the Fracture Rate in Postmenopausal Women with OsteoporosisNew England Journal of Medicine, 1990
- RISING INCIDENCE OF FRACTURE OF THE PROXIMAL FEMURThe Lancet, 1985
- Reduction of lecithin-cholesterol acyltransferase, apolipoprotein D and the Lp(a) lipoprotein with the anabolic steroid stanozololBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1984
- The Hospital Anxiety and Depression ScaleActa Psychiatrica Scandinavica, 1983
- Lower Calcitonin Levels in Young Hypogonadic Men with OsteoporosisHormone and Metabolic Research, 1983
- A scaled version of the General Health QuestionnairePsychological Medicine, 1979